Alzheimer's disease represents an enormous global burden in terms of human suffering and economic cost. To tackle the current lack of effective drugs and the continuous clinical trial failures might require a shift from the prevailing paradigm targeting pathogenesis to the one targeting neural stem cells (NSCs) regeneration. In this context, small molecules have come to the forefront for their potential to manipulate NSCs, provide therapeutic tools and unveil NSCs biology. Classically, these molecules have been generated either by target-based or phenotypic approaches. To circumvent specific liabilities, nanomedicines emerge as a feasible alternative. However, this review is not intended to be comprehensive. Its purpose is to focus on recent examples that could accelerate development of neuroregenerative drugs against Alzheimer's disease.

Uliassi, E., Gandini, A., Perone, R.C., Bolognesi, M.L. (2017). Neuroregeneration versus neurodegeneration: Toward a paradigm shift in Alzheimer's disease drug discovery. FUTURE MEDICINAL CHEMISTRY, 9(10), 995-1013 [10.4155/fmc-2017-0038].

Neuroregeneration versus neurodegeneration: Toward a paradigm shift in Alzheimer's disease drug discovery

Uliassi, Elisa;Gandini, Annachiara;Perone, Rosaria Carmela;Bolognesi, Maria Laura
2017

Abstract

Alzheimer's disease represents an enormous global burden in terms of human suffering and economic cost. To tackle the current lack of effective drugs and the continuous clinical trial failures might require a shift from the prevailing paradigm targeting pathogenesis to the one targeting neural stem cells (NSCs) regeneration. In this context, small molecules have come to the forefront for their potential to manipulate NSCs, provide therapeutic tools and unveil NSCs biology. Classically, these molecules have been generated either by target-based or phenotypic approaches. To circumvent specific liabilities, nanomedicines emerge as a feasible alternative. However, this review is not intended to be comprehensive. Its purpose is to focus on recent examples that could accelerate development of neuroregenerative drugs against Alzheimer's disease.
2017
Uliassi, E., Gandini, A., Perone, R.C., Bolognesi, M.L. (2017). Neuroregeneration versus neurodegeneration: Toward a paradigm shift in Alzheimer's disease drug discovery. FUTURE MEDICINAL CHEMISTRY, 9(10), 995-1013 [10.4155/fmc-2017-0038].
Uliassi, Elisa; Gandini, Annachiara; Perone, Rosaria Carmela; Bolognesi, Maria Laura*
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/621352
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 17
social impact